1.Discussion on the Treatment of Tumor-related Insomnia from"Heat Toxicity"
Chongyang QU ; Yinghua LI ; Shuzhen DUAN ; Rong MA ; Chunfang TIAN ; Min LIU ; Yuanyuan GUO ; Hongzhen YIN ; Shaobo HU ; Jie LI
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(7):172-175
Tumor-related insomnia is one of the common complications of tumor patients,which is secondary to tumor disease and related to tumor disease itself or tumor treatment.Combined with the unique pathogenesis of"heat-toxicity internal stagnation"of tumor-related insomnia,the important treatment methods are to clear away heat,attack toxicity,regulate qi and supplement healthy qi.This article explained the research status,etiology and pathogenesis,treatment principles of the disease,in order to provide new ideas and methods for the differentiation and treatment of tumor-related insomnia in TCM.
2.Clinical distribution and antimicrobial resistance of 47 strains of Ralstonia mannitolilytica
Qiongya HU ; Jiao PENG ; Chuangjie YANG ; Jingyong SUN ; Shuzhen XIAO
Chinese Journal of Infection and Chemotherapy 2025;25(4):413-417
Objective To analyze the clinical distribution and antimicrobial susceptibility of Ralstonia mannitolilytica strains isolated from clinical specimens at a tertiary hospital in Shanghai.The results could inform better clinical treatment of R.mannitolilytica.Methods A total of 47 R.mannitolilytica isolated from January 2022 to August 2024 were collected.The clinical data of patients from whom these strains were isolated were reviewed and analyzed.Results The 47 strains of R.mannitolilytica were mainly isolated from hematology department(85.1%,40/47)and intensive care unit(4.3%,2/47).In the 47 patients with R.mannitolilytica isolate,83.0%had hematological disease and 85.1%stayed in hospital for at least 28 days.Overall,63.8%of the 47 patients used antibiotics for at least 3 weeks and 76.6%of the patients used at least three types of antibiotics during hospital stay.All of the 47 R.mannitolilytica strains were resistant to aztreonam,while 84.6%,83.3%,70.4%,and 69.6%of the strains were resistant to meropenem,ticarcillin-clavulanate acid,ceftazidime,and piperacillin-tazobactam,respectively,58.7%,55.8%,52.2%,and 42.2%of the strains were resistant to amikacin,tobramycin,cefepime,and imipenem,respectively.In contrast,88.1%,83.3%,82.9%,67.4%and 60.5%of the strains were susceptible to minocycline,doxycycline,cotrimoxazole,ciprofloxacin,and levofloxacin,respectively.Conclusions Most of the R.mannitolilytica strains were multi-drug resistant.The bacteria is more prevalent in patients with hematological disorders and long-term treatment with multiple broad-spectrum antimicrobial agents.
3.Exploration on the mechanism of lung cancer treatment from the perspective of phlegm pathogen theory based on inflammatory-metabolic-immune microenvironment
Yuanjiafan CHEN ; Yaxing LI ; Shaobo HU ; Hongzhen YIN ; Chongyang QU ; Shuzhen DUAN ; Yinghua LI ; Jie LI
International Journal of Traditional Chinese Medicine 2025;47(10):1341-1346
The tumor microenvironment (TME) is the cellular milieu in which tumor cells thrive, comprising interacting cells and associated factors that form a complex network of interactions, directly or indirectly influencing the initiation, progression, and metastasis of lung cancer. Through TCM pattern identification, it has been observed thatphlegm-pathogen is closely associated with disorder in the inflammatory-metabolic-immune microenvironments of lung cancer. This involves three key pathological mechanisms: "phlegm-stasis complicated by toxin, qi deficiency with exuberant phlegm, and phlegm-pathogen impairing healthy qi". Molecular mechanism studies have revealed that phlegm-resolving agents can extensively modulate multiple targets or pathways, thereby remodeling the inflammatory-metabolic-immune microenvironments of lung cancer. Consequently, a comprehensive therapeutic strategy integrating "resolving phlegm, dispelling stasis, and detoxifying; supplementing qi, warming yang, and resolving phlegm; and reinforcing healthy qi, tonifying the lung, and eliminating phlegm" is essential to reshape the lung cancer TME and enhance antitumor efficacy.
4.Treatment of Tumor Cachexia Based on the Pathogenesis of"Spleen and Kidney Exhaustion and Internal Accumulation of Turbid Toxins"
Chongyang QU ; Yinghua LI ; Shuzhen DUAN ; Rong MA ; Chunfang TIAN ; Min LIU ; Yuanyuan GUO ; Hongzhen YIN ; Shaobo HU ; Jie LI
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(12):160-164
Cancer cachexia is a complex syndrome caused by multiple factors,which seriously affects the quality of life and prognosis of patients.Its overall pathogenesis is related to the deficiency of spleen qi,insufficiency of kidney essence,internal generation of turbid toxins,and the obstruction of the production of qi,blood and essential qi,which cannot nourish the muscles and bones.Under the guidance of the dynamic diagnosis and treatment system of"spleen and kidney exhaustion as the root cause and internal accumulation of turbid toxins as the manifestation",the overall regulation is carried out from four dimensions:opening and closing the spleen and stomach,nourishing the kidney and promoting transportation,transforming turbid toxins and detoxification,and tonifying qi and nourishing yin.It has shown unique value in the intervention of cancer cachexia and can provide ideas and references for the clinical practice of TCM in treating cancer cachexia.
5.Interpretation of Chinese Expert Consensus on Integrated Chinese and Western Medicine Management of Wilson Disease-related Renal Damage
Wenming YANG ; Ke DIAO ; Hu XI ; Zhihong RAO ; Taohua WEI ; Yulong YANG ; Shuzhen FANG
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(20):168-176
Wilson disease is a copper metabolism disorder caused by mutations in the ATP7B gene, which encodes a copper-transporting ATPase β, and can result in multisystem damage. The kidneys are the third most commonly affected organs after the liver and brain. In recent years, numerous diagnostic and treatment guidelines for Wilson disease have emerged. However, most of these focus primarily on hepatic and neurological manifestations and their management, with limited coverage of renal involvement. The high incidence, low awareness, and lack of clinical specificity of Wilson disease-related renal damage (WDRD) have made early detection and intervention particularly challenging in clinical practice. To further optimize the treatment of patients with WDRD, improve clinical diagnosis and management, and enhance patients' quality of life, the Neurology Committee of the Chinese Association of Integrative Medicine, in April 2024, initiated a revision of the first expert consensus on the integrated diagnosis, treatment, and management of WDRD. This effort brought together experts in hepatology, encephalopathy (neurology), and nephrology from many tertiary-level grade A hospitals and research institutions across China. Through comprehensive literature review and integration of frontline clinical experience, the expert group jointly developed Chinese Expert Consensus on Integrated Chinese and Western Medicine Management of Wilson Disease-related Renal Damage (hereinafter referred to as the "Consensus"). This article provides a detailed interpretation of the Consensus in terms of diagnostic criteria, traditional Chinese medicine (TCM) syndrome differentiation and treatment classification, and comprehensive disease management, aiming to better guide clinical application. Regarding diagnostic criteria, the Consensus integrates the latest standards in China and abroad, highlights the importance of biochemical diagnosis, and compensates for the limitations of genetic testing. In the area of TCM syndrome differentiation and treatment, the Consensus refines four major syndrome types, introduces a newly defined syndrome, i.e., phlegm, blood stasis, and heat accumulation, and elaborates on treatment principles, prescriptions, and clinical modification rules for each syndrome. For comprehensive disease management, the Consensus emphasizes multi-dimensional intervention strategies, including diet, exercise, emotional regulation, medication, and medical care, with the goal of maximally controlling the progression of renal dysfunction and helping patients achieve a better quality of life.
6.Clinical distribution and antimicrobial resistance of 47 strains of Ralstonia mannitolilytica
Qiongya HU ; Jiao PENG ; Chuangjie YANG ; Jingyong SUN ; Shuzhen XIAO
Chinese Journal of Infection and Chemotherapy 2025;25(4):413-417
Objective To analyze the clinical distribution and antimicrobial susceptibility of Ralstonia mannitolilytica strains isolated from clinical specimens at a tertiary hospital in Shanghai.The results could inform better clinical treatment of R.mannitolilytica.Methods A total of 47 R.mannitolilytica isolated from January 2022 to August 2024 were collected.The clinical data of patients from whom these strains were isolated were reviewed and analyzed.Results The 47 strains of R.mannitolilytica were mainly isolated from hematology department(85.1%,40/47)and intensive care unit(4.3%,2/47).In the 47 patients with R.mannitolilytica isolate,83.0%had hematological disease and 85.1%stayed in hospital for at least 28 days.Overall,63.8%of the 47 patients used antibiotics for at least 3 weeks and 76.6%of the patients used at least three types of antibiotics during hospital stay.All of the 47 R.mannitolilytica strains were resistant to aztreonam,while 84.6%,83.3%,70.4%,and 69.6%of the strains were resistant to meropenem,ticarcillin-clavulanate acid,ceftazidime,and piperacillin-tazobactam,respectively,58.7%,55.8%,52.2%,and 42.2%of the strains were resistant to amikacin,tobramycin,cefepime,and imipenem,respectively.In contrast,88.1%,83.3%,82.9%,67.4%and 60.5%of the strains were susceptible to minocycline,doxycycline,cotrimoxazole,ciprofloxacin,and levofloxacin,respectively.Conclusions Most of the R.mannitolilytica strains were multi-drug resistant.The bacteria is more prevalent in patients with hematological disorders and long-term treatment with multiple broad-spectrum antimicrobial agents.
7.Discussion on the Treatment of Tumor-related Insomnia from"Heat Toxicity"
Chongyang QU ; Yinghua LI ; Shuzhen DUAN ; Rong MA ; Chunfang TIAN ; Min LIU ; Yuanyuan GUO ; Hongzhen YIN ; Shaobo HU ; Jie LI
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(7):172-175
Tumor-related insomnia is one of the common complications of tumor patients,which is secondary to tumor disease and related to tumor disease itself or tumor treatment.Combined with the unique pathogenesis of"heat-toxicity internal stagnation"of tumor-related insomnia,the important treatment methods are to clear away heat,attack toxicity,regulate qi and supplement healthy qi.This article explained the research status,etiology and pathogenesis,treatment principles of the disease,in order to provide new ideas and methods for the differentiation and treatment of tumor-related insomnia in TCM.
8.Treatment of Tumor Cachexia Based on the Pathogenesis of"Spleen and Kidney Exhaustion and Internal Accumulation of Turbid Toxins"
Chongyang QU ; Yinghua LI ; Shuzhen DUAN ; Rong MA ; Chunfang TIAN ; Min LIU ; Yuanyuan GUO ; Hongzhen YIN ; Shaobo HU ; Jie LI
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(12):160-164
Cancer cachexia is a complex syndrome caused by multiple factors,which seriously affects the quality of life and prognosis of patients.Its overall pathogenesis is related to the deficiency of spleen qi,insufficiency of kidney essence,internal generation of turbid toxins,and the obstruction of the production of qi,blood and essential qi,which cannot nourish the muscles and bones.Under the guidance of the dynamic diagnosis and treatment system of"spleen and kidney exhaustion as the root cause and internal accumulation of turbid toxins as the manifestation",the overall regulation is carried out from four dimensions:opening and closing the spleen and stomach,nourishing the kidney and promoting transportation,transforming turbid toxins and detoxification,and tonifying qi and nourishing yin.It has shown unique value in the intervention of cancer cachexia and can provide ideas and references for the clinical practice of TCM in treating cancer cachexia.
9.The imaging presentations of the fallopian canal cerebrospinal fluid leaking
Linsheng WANG ; Lihong ZHANG ; Shanfeng LIU ; Na HU ; Jinye LI ; Shuzhen HAO ; Ruozhen GONG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2024;59(2):147-151
Objective:To summarize the imaging presentations of the fallopian canal cerebrospinal fluid leaking (FCCFL).Methods:The high resolution CT (HRCT)and MRI materials of 4 patients (4 ears) with FCCFL confirmed by surgery between August 2016 to November 2023 were retrospectively analyzed. Among these, there were 2 males and 2 females, their ages ranged from 6 to 69 years.Results:All of the FCCFL were unilateral, including 2 on the left and 2 on the right.Clinically, the patients with FCCFL suffered from clear nasal fluid flow, ear tightness, and hearing loss. On CT, all of the affected ears were depicted markedly dilatation of the proximal portion of fallopian canal(FC), the labyrinthine segment and geniculate fossa were involved in 4 cases, and involvement of tympanic segment in 1 case at the same time. The geniculate fossa in the affected side were significantly enlarged, protruding upwards into the tympanic cavity, with one case simultaneously involving the cochlea. On MRI, the hyposignal on T 1WI and hypersignal on T 2WI or water sequence like cerebrospinal fluid (CSF) were shown in the enlargement FC, without diffusion restriction, and non-enhancing with administration Gadolinium contrast.CSF-like signal effusion was shown in all of the affected tympanum, of which, the CSF-like signal effusion was demonstrated in the area along the superficial petrosal nerve, the right pterygopalatine fossa and the parapharyngeal space. The adjacent intracranial meninges were presented thickening in 3 cases. Conclusion:The imaging appearances of FCCFL present some characteristics:on HRCT, the proximal portions of the affected FC depicts markedly enlargement,especially the geniculate fossa.While they present CSF-like signal, no diffusion restriction, and no enhancement administration, Gadolinium contrast on MRI, accompanying the CSF-like signal effusion in the affected tympanum.
10.Efficacy of retrograde intramedullary nailing in managing tibial osteofibrous dysplasia in pediatric patients
Zhaoqiang CHEN ; Jianping YANG ; Zhongli ZHANG ; Yongcheng HU ; Zhe FU ; Kan WANG ; Shuzhen DENG
Chinese Journal of Orthopaedics 2024;44(5):308-314
Objective:To delineate the surgical methodology and therapeutic paradigm of proximal tibial notch retrograde interlocking intramedullary nailing for ameliorating deformities due to osteofibrous dysplasia (OFD) in a pediatric population.Methods:A retrospective assessment was conducted on the medical records of individuals undergoing orthopedic osteotomy complemented by retrograde interlocking intramedullary nailing for OFD of the tibia from January 2016 to December 2019. The cohort comprised 15 patients, with a follow-up exceeding three years, documenting complete data sets. The patient profile included 8 males and 7 females, with 8 left-side and 7 right-side afflictions. The mean age at the time of surgery was 10.1±2.5 years, ranging from 7.1 to 12.6 years. Parameters measured were preoperative and postoperative imaging findings, which encompassed the scope of the lesion (longitudinal lesion length relative to tibial length), coronal and sagittal limb alignments, and lower limb length discrepancies.Results:The mean follow-up duration was 3.4±1.3 years, ranging from 3 to 6.6 years. Preoperatively, prominent anterior tibial arch deformities and limping were present, with 7 cases reporting fatigue-induced pain and 3 instances of pathological fractures. Post-surgery, pain symptoms were resolved, gait disturbances were improved in 9 patients, and completely resolved in 6. Tibial osteotomy or fracture healing of 15 patients averaged 3.9±0.7 months (range 3-5 months). The lesion range before surgery was 0.41±0.17, immediately after surgery was 0.38±0.17, and at the last follow-up was 0.30±0.16, with no statistical significance ( F=0.101, P=0.904). Lesion range showed no significant change throughout treatment, but radiographic density within the lesion notably increased post-surgery, suggesting bone improvement. The anterior tibial arch Angle was 28.30°±6.62° (range 20°-45°) before surgery, 4.73°±1.53° immediately after surgery, and 6.87°±1.36° at the last follow-up, with statistical significance ( F=159.739, P<0.001). A significant correction in the anterior tibial arch deformity was achieved and maintained postoperatively. There was no significant angular deformity of the tibia in the coronal plane before operation, and the medial proximal tibial angle (MPTA) and lateral distal tibial angle (LDTA) were 87.50°±1.46° and 88.30°±1.62°, 88.40°±1.46° and 88.70°±1.45° immediately after surgery, and 88.00°±1.39° and 89.10°±1.53° at the last follow-up, the differences were statistically significant ( F=1.741, P=0.188; F=1.016, P=0.371), there was no coronal deformity of tibia. The limb length discrepancy (LLD) was 0.60±0.98 cm before surgery, 0.18±0.93 cm at the last follow-up, with statistical significance ( t=0.096, P=0.761). There were no incidents of postoperative complications such as infection. Conclusion:In pediatric cases of tibial deformities attributed to osteofibrous dysplasia, a therapeutic strategy involving osteotomy for lower limb realignment, sans curettage or bone grafting of the lesion, followed by retrograde interlocking intramedullary nailing, yields favorable outcomes. Importantly, this implantation technique does not compromise the integrity of the proximal tibial epiphyseal plate in children and adolescents.

Result Analysis
Print
Save
E-mail